Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 48

1.

Genome analysis of myelodysplastic syndromes among atomic bomb survivors in Nagasaki.

Taguchi M, Mishima H, Shiozawa Y, Hayashida C, Kinoshita A, Nannya Y, Makishima H, Horai M, Matsuo M, Sato S, Itonaga H, Kato T, Taniguchi H, Imanishi D, Imaizumi Y, Hata T, Takenaka M, Moriuchi Y, Shiraishi Y, Miyano S, Ogawa S, Yoshiura KI, Miyazaki Y.

Haematologica. 2020 Jan 31;105(2):358-365. doi: 10.3324/haematol.2019.219386. Print 2020.

2.

[Enteropathy-associated T-cell lymphoma coexisting with composite lymphoma composed of DLBCL and PTCL].

Imanishi D, Hata T, Imaizumi Y, Niino D, Ohshima K, Miyazaki Y.

Rinsho Ketsueki. 2019;60(3):197-202. doi: 10.11406/rinketsu.60.197. Japanese.

PMID:
31068515
3.

Draft Genome Sequence of the Yeast Vanrija humicola (Formerly Cryptococcus humicola) Strain UJ1, a Producer of d-Aspartate Oxidase.

Imanishi D, Abe K, Kera Y, Takahashi S.

Genome Announc. 2018 Mar 15;6(11). pii: e00068-18. doi: 10.1128/genomeA.00068-18.

4.

Clonal dynamics in a case of acute monoblastic leukemia that later developed myeloproliferative neoplasm.

Sato S, Itonaga H, Taguchi M, Sawayama Y, Imanishi D, Tsushima H, Hata T, Moriuchi Y, Mishima H, Kinoshita A, Yoshiura KI, Miyazaki Y.

Int J Hematol. 2018 Aug;108(2):213-217. doi: 10.1007/s12185-018-2419-1. Epub 2018 Feb 7.

PMID:
29417354
5.

Detection of de novo single nucleotide variants in offspring of atomic-bomb survivors close to the hypocenter by whole-genome sequencing.

Horai M, Mishima H, Hayashida C, Kinoshita A, Nakane Y, Matsuo T, Tsuruda K, Yanagihara K, Sato S, Imanishi D, Imaizumi Y, Hata T, Miyazaki Y, Yoshiura KI.

J Hum Genet. 2018 Mar;63(3):357-363. doi: 10.1038/s10038-017-0392-9. Epub 2017 Dec 26.

PMID:
29279608
6.

Clinical features and prognosis of patients with myelodysplastic syndromes who were exposed to atomic bomb radiation in Nagasaki.

Matsuo M, Iwanaga M, Kondo H, Soda M, Jo T, Horio K, Takasaki Y, Kawaguchi Y, Tsushima H, Imaizumi Y, Imanishi D, Taguchi J, Sawayama Y, Hata T, Miyazaki Y.

Cancer Sci. 2016 Oct;107(10):1484-1491. doi: 10.1111/cas.13025. Epub 2016 Sep 2.

7.

Simultaneous screening for JAK2 and calreticulin gene mutations in myeloproliferative neoplasms with high resolution melting.

Matsumoto N, Mori S, Hasegawa H, Sasaki D, Mori H, Tsuruda K, Imanishi D, Imaizumi Y, Hata T, Kaku N, Kosai K, Uno N, Miyazaki Y, Yanagihara K.

Clin Chim Acta. 2016 Nov 1;462:166-173. doi: 10.1016/j.cca.2016.09.023. Epub 2016 Sep 29.

8.

The level of bone marrow WT1 message is a useful marker to differentiate myelodysplastic syndromes with low blast percentage from cytopenia due to other reasons.

Baba M, Hata T, Tsushima H, Mori S, Sasaki D, Turuta K, Hasegawa H, Ando K, Sawayama Y, Imanishi D, Taguchi J, Yanagihara K, Tomonaga M, Kamihira S, Miyazaki Y.

Intern Med. 2015;54(5):445-51. doi: 10.2169/internalmedicine.54.3123. Epub 2015 Jan 15.

9.

Characteristic patterns of relapse after allogeneic hematopoietic SCT for adult T-cell leukemia-lymphoma: a comparative study of recurrent lesions after transplantation and chemotherapy by the Nagasaki Transplant Group.

Itonaga H, Sawayama Y, Taguchi J, Honda S, Taniguchi H, Makiyama J, Matsuo E, Sato S, Ando K, Imanishi D, Imaizumi Y, Yoshida S, Hata T, Moriuchi Y, Fukushima T, Miyazaki Y.

Bone Marrow Transplant. 2015 Apr;50(4):585-91. doi: 10.1038/bmt.2014.308. Epub 2015 Jan 26.

PMID:
25621801
10.

Molecular analysis of loss of CCR4 expression during mogamulizumab monotherapy in an adult T cell leukemia/lymphoma patient.

Taguchi M, Imaizumi Y, Sasaki D, Higuchi T, Tsuruda K, Hasegawa H, Taguchi J, Sawayama Y, Imanishi D, Hata T, Yanagihara K, Yoshie O, Miyazaki Y.

Ann Hematol. 2015 Apr;94(4):693-5. doi: 10.1007/s00277-014-2239-1. Epub 2014 Oct 23. No abstract available.

PMID:
25338968
11.

Heat shock protein 90 inhibitor NVP-AUY922 exerts potent activity against adult T-cell leukemia-lymphoma cells.

Taniguchi H, Hasegawa H, Sasaki D, Ando K, Sawayama Y, Imanishi D, Taguchi J, Imaizumi Y, Hata T, Tsukasaki K, Uno N, Morinaga Y, Yanagihara K, Miyazaki Y.

Cancer Sci. 2014 Dec;105(12):1601-8. doi: 10.1111/cas.12540. Epub 2014 Nov 5.

12.

Lessons from the atomic bomb about secondary MDS.

Hata T, Imanishi D, Miyazaki Y.

Curr Hematol Malig Rep. 2014 Dec;9(4):407-11. doi: 10.1007/s11899-014-0235-0. Review.

PMID:
25240475
13.

Treatment outcome of elderly patients with aggressive adult T cell leukemia-lymphoma: Nagasaki University Hospital experience.

Makiyama J, Imaizumi Y, Tsushima H, Taniguchi H, Moriwaki Y, Sawayama Y, Imanishi D, Taguchi J, Hata T, Tsukasaki K, Miyazaki Y.

Int J Hematol. 2014 Nov;100(5):464-72. doi: 10.1007/s12185-014-1665-0. Epub 2014 Sep 11.

PMID:
25209605
14.

[Successful treatment with a combination of lenalidomide and dexamethasone for cryoglobulinemia associated with multiple myeloma].

Taniguchi H, Imaizumi Y, Makiyama J, Ando K, Sawayama Y, Imanishi D, Taguchi J, Tsushima H, Hata T, Miyazaki Y.

Rinsho Ketsueki. 2014 Aug;55(8):953-7. Japanese.

PMID:
25186485
15.

Longitudinal Analysis of DNA Methylation in CD34+ Hematopoietic Progenitors in Myelodysplastic Syndrome.

Wong YF, Micklem CN, Taguchi M, Itonaga H, Sawayama Y, Imanishi D, Nishikawa S, Miyazaki Y, Jakt LM.

Stem Cells Transl Med. 2014 Oct;3(10):1188-98. doi: 10.5966/sctm.2014-0035. Epub 2014 Aug 13.

16.

Infliximab therapy for Crohn's-like disease in common variable immunodeficiency complicated by massive intestinal hemorrhage: a case report.

Akazawa Y, Takeshima F, Yajima H, Imanishi D, Kanda T, Matsushima K, Minami H, Yamaguchi N, Ohnita K, Isomoto H, Hayashi T, Nakashima M, Nakao K.

BMC Res Notes. 2014 Jun 22;7:382. doi: 10.1186/1756-0500-7-382.

17.

Expression of myeloperoxidase in acute myeloid leukemia blasts mirrors the distinct DNA methylation pattern involving the downregulation of DNA methyltransferase DNMT3B.

Itonaga H, Imanishi D, Wong YF, Sato S, Ando K, Sawayama Y, Sasaki D, Tsuruda K, Hasegawa H, Imaizumi Y, Taguchi J, Tsushima H, Yoshida S, Fukushima T, Hata T, Moriuchi Y, Yanagihara K, Miyazaki Y.

Leukemia. 2014 Jul;28(7):1459-66. doi: 10.1038/leu.2014.15. Epub 2014 Jan 10.

PMID:
24457336
18.

[Outcome of patients with relapsed/refractory adult T-cell leukemia-lymphoma after salvage therapy].

Taniguchi H, Imaizumi Y, Makiyama J, Itonaga H, Ando K, Sawayama Y, Imanishi D, Taguchi J, Tsushima H, Hata T, Hasegawa H, Hayashi T, Niino D, Ohshima K, Tsukasaki K, Miyazaki Y.

Rinsho Ketsueki. 2013 Dec;54(12):2159-66. Japanese.

PMID:
24452146
19.

Molecular analysis of the BCR-ABL1 kinase domain in chronic-phase chronic myelogenous leukemia treated with tyrosine kinase inhibitors in practice: study by the Nagasaki CML Study Group.

Itonaga H, Tsushima H, Imanishi D, Hata T, Doi Y, Mori S, Sasaki D, Hasegawa H, Matsuo E, Nakashima J, Kato T, Horai M, Taguchi M, Matsuo M, Taniguchi H, Makiyama J, Sato S, Horio K, Ando K, Moriwaki Y, Sawayama Y, Ogawa D, Yamasaki R, Takasaki Y, Imaizumi Y, Taguchi J, Kawaguchi Y, Yoshida S, Joh T, Moriuchi Y, Nonaka H, Soda H, Fukushima T, Nagai K, Kamihira S, Tomonaga M, Yanagihara K, Miyazaki Y.

Leuk Res. 2014 Jan;38(1):76-83. doi: 10.1016/j.leukres.2013.10.022. Epub 2013 Nov 5.

PMID:
24262285
20.

Long-term outcome of immunosuppressive therapy for Japanese patients with lower-risk myelodysplastic syndromes.

Hata T, Tsushima H, Baba M, Imaizumi Y, Taguchi J, Imanishi D, Nagai K, Tomonaga M, Miyazaki Y.

Int J Hematol. 2013 Dec;98(6):687-93. doi: 10.1007/s12185-013-1468-8. Epub 2013 Nov 20.

PMID:
24254637
21.

Transient proliferation of donor-derived ATL cell-like lymphocytes early after allogeneic stem cell transplantation in an adult T-cell leukemia/lymphoma patient.

Taguchi M, Imaizumi Y, Taguchi J, Imanishi D, Sasaki D, Hasegawa H, Tsushima H, Hata T, Miyazaki Y.

Blood. 2013 May 23;121(21):4428-30. doi: 10.1182/blood-2013-02-487652. No abstract available.

PMID:
23704050
22.

Feasibility of cord blood transplantation in chemosensitive adult T-cell leukemia/lymphoma: a retrospective analysis of the Nagasaki Transplantation Network.

Fukushima T, Itonaga H, Moriuchi Y, Yoshida S, Taguchi J, Imaizumi Y, Imanishi D, Tsushima H, Sawayama Y, Matsuo E, Hata T, Miyazaki Y.

Int J Hematol. 2013 Apr;97(4):485-90. doi: 10.1007/s12185-013-1307-y. Epub 2013 Mar 13.

PMID:
23483425
23.

Mutations in the nucleolar phosphoprotein, nucleophosmin, promote the expression of the oncogenic transcription factor MEF/ELF4 in leukemia cells and potentiates transformation.

Ando K, Tsushima H, Matsuo E, Horio K, Tominaga-Sato S, Imanishi D, Imaizumi Y, Iwanaga M, Itonaga H, Yoshida S, Hata T, Moriuchi R, Kiyoi H, Nimer S, Mano H, Naoe T, Tomonaga M, Miyazaki Y.

J Biol Chem. 2013 Mar 29;288(13):9457-67. doi: 10.1074/jbc.M112.415703. Epub 2013 Feb 7.

24.

Distinct clinical features of infectious complications in adult T cell leukemia/lymphoma patients after allogeneic hematopoietic stem cell transplantation: a retrospective analysis in the Nagasaki transplant group.

Itonaga H, Taguchi J, Fukushima T, Tsushima H, Sato S, Ando K, Sawayama Y, Matsuo E, Yamasaki R, Onimaru Y, Imanishi D, Imaizumi Y, Yoshida S, Hata T, Moriuchi Y, Honda S, Miyazaki Y.

Biol Blood Marrow Transplant. 2013 Apr;19(4):607-15. doi: 10.1016/j.bbmt.2013.01.011. Epub 2013 Jan 17.

25.

Treatment of relapsed adult T-cell leukemia/lymphoma after allogeneic hematopoietic stem cell transplantation: the Nagasaki Transplant Group experience.

Itonaga H, Tsushima H, Taguchi J, Fukushima T, Taniguchi H, Sato S, Ando K, Sawayama Y, Matsuo E, Yamasaki R, Onimaru Y, Imanishi D, Imaizumi Y, Yoshida S, Hata T, Moriuchi Y, Uike N, Miyazaki Y.

Blood. 2013 Jan 3;121(1):219-25. doi: 10.1182/blood-2012-07-444372. Epub 2012 Oct 24.

PMID:
23100309
26.

Successful treatment of a chronic-phase T-315I-mutated chronic myelogenous leukemia patient with a combination of imatinib and interferon-alfa.

Itonaga H, Tsushima H, Hata T, Matsuo E, Imanishi D, Imaizumi Y, Kawaguchi Y, Fukushima T, Doi Y, Mori S, Kamihira S, Tomonaga M, Miyazaki Y.

Int J Hematol. 2012 Feb;95(2):209-13. doi: 10.1007/s12185-012-1005-1. Epub 2012 Jan 20.

PMID:
22262141
27.

[Acute monoblastic leukemia following granular lymphocyte proliferative disorder].

Itonaga H, Fukushima T, Taguchi J, Imanishi D, Imaizumi Y, Hata T, Tsukasaki K, Miyazaki Y.

Rinsho Ketsueki. 2011 Dec;52(12):1870-5. Japanese.

PMID:
22241154
28.

Allogeneic hematopoietic stem cell transplantation for ATL with central nervous system involvement: the Nagasaki transplant group experience.

Fukushima T, Taguchi J, Moriuchi Y, Yoshida S, Itonaga H, Ando K, Sawayama Y, Imaizumi Y, Imanishi D, Hata T, Miyazaki Y.

Int J Hematol. 2011 Oct;94(4):390-394. doi: 10.1007/s12185-011-0935-3. Epub 2011 Sep 30.

PMID:
21960057
29.

Expression of myeloperoxidase and gene mutations in AML patients with normal karyotype: double CEBPA mutations are associated with high percentage of MPO positivity in leukemic blasts.

Tominaga-Sato S, Tsushima H, Ando K, Itonaga H, Imaizumi Y, Imanishi D, Iwanaga M, Taguchi J, Fukushima T, Yoshida S, Hata T, Moriuchi Y, Kuriyama K, Mano H, Tomonaga M, Miyazaki Y.

Int J Hematol. 2011 Jul;94(1):81-89. doi: 10.1007/s12185-011-0883-y. Epub 2011 Jun 16. Erratum in: Int J Hematol. 2012 Aug;96(2):291-2.

PMID:
21674360
30.

A case of intravascular large B-cell lymphoma (IVLBCL) with no abnormal findings on chest computed tomography diagnosed by random transbronchial lung biopsy.

Kaku N, Seki M, Doi S, Hayashi T, Imanishi D, Imamura Y, Kurihara S, Miyazaki T, Izumikawa K, Kakeya H, Yamamoto Y, Yanagihara K, Tashiro T, Kohno S.

Intern Med. 2010;49(24):2697-701. Epub 2010 Dec 15. Review.

31.

High expression of 67-kDa laminin receptor relates to the proliferation of leukemia cells and increases expression of GM-CSF receptor.

Ando K, Miyazaki Y, Sawayama Y, Tominaga S, Matsuo E, Yamasaki R, Inoue Y, Iwanaga M, Imanishi D, Tsushima H, Fukushima T, Imaizumi Y, Taguchi J, Yoshida S, Hata T, Tomonaga M.

Exp Hematol. 2011 Feb;39(2):179-186.e4. doi: 10.1016/j.exphem.2010.11.001. Epub 2010 Nov 4.

PMID:
21056082
32.

Comparative analysis of remission induction therapy for high-risk MDS and AML progressed from MDS in the MDS200 study of Japan Adult Leukemia Study Group.

Morita Y, Kanamaru A, Miyazaki Y, Imanishi D, Yagasaki F, Tanimoto M, Kuriyama K, Kobayashi T, Imoto S, Ohnishi K, Naoe T, Ohno R.

Int J Hematol. 2010 Jan;91(1):97-103. doi: 10.1007/s12185-009-0473-4. Epub 2010 Jan 5.

PMID:
20047095
33.

Isoniazid-triggered pure red cell aplasia in systemic lupus erythematosus complicated with myasthenia gravis.

Nakamura H, Okada A, Kawakami A, Yamasaki S, Ida H, Motomura M, Imanishi D, Eguchi K.

Rheumatol Int. 2010 Nov;30(12):1643-5. doi: 10.1007/s00296-009-1113-2. Epub 2009 Aug 25.

PMID:
19705120
34.

Long-term efficacy of imatinib in a practical setting is correlated with imatinib trough concentration that is influenced by body size: a report by the Nagasaki CML Study Group.

Sakai M, Miyazaki Y, Matsuo E, Moriuchi Y, Hata T, Fukushima T, Imaizumi Y, Imanishi D, Taguchi J, Iwanaga M, Tsushima H, Inoue Y, Takasaki Y, Tsuchiya T, Komoda M, Ando K, Horio K, Moriwaki Y, Tominaga S, Itonaga H, Nagai K, Tsukasaki K, Tsutsumi C, Sawayama Y, Yamasaki R, Ogawa D, Kawaguchi Y, Ikeda S, Yoshida S, Onimaru Y, Tawara M, Atogami S, Koida S, Joh T, Yamamura M, Matsuo Y, Soda H, Nonaka H, Jinnai I, Kuriyama K, Tomonaga M.

Int J Hematol. 2009 Apr;89(3):319-325. doi: 10.1007/s12185-009-0263-z. Epub 2009 Mar 6.

PMID:
19266256
35.

Successful cord blood transplantation for mycosis fungoides.

Fukushima T, Horio K, Matsuo E, Imanishi D, Yamasaki R, Tsushima H, Imaizumi Y, Ohshima K, Hata T, Yoshida S, Miyazaki Y, Tomonaga M.

Int J Hematol. 2008 Dec;88(5):596-598. doi: 10.1007/s12185-008-0190-4. Epub 2008 Nov 8.

PMID:
18998050
36.

Relationship between monoclonal gammopathy of undetermined significance and radiation exposure in Nagasaki atomic bomb survivors.

Iwanaga M, Tagawa M, Tsukasaki K, Matsuo T, Yokota K, Miyazaki Y, Fukushima T, Hata T, Imaizumi Y, Imanishi D, Taguchi J, Momita S, Kamihira S, Tomonaga M.

Blood. 2009 Feb 19;113(8):1639-50. doi: 10.1182/blood-2008-05-159665. Epub 2008 Oct 10.

PMID:
18849487
37.

Expression of myeloperoxidase enhances the chemosensitivity of leukemia cells through the generation of reactive oxygen species and the nitration of protein.

Sawayama Y, Miyazaki Y, Ando K, Horio K, Tsutsumi C, Imanishi D, Tsushima H, Imaizumi Y, Hata T, Fukushima T, Yoshida S, Onimaru Y, Iwanaga M, Taguchi J, Kuriyama K, Tomonaga M.

Leukemia. 2008 May;22(5):956-64. doi: 10.1038/leu.2008.8. Epub 2008 Feb 14.

PMID:
18273043
38.

Human herpes virus 8-negative primary effusion lymphoma with BCL6 rearrangement in a patient with idiopathic CD4 positive T-lymphocytopenia.

Niino D, Tsukasaki K, Torii K, Imanishi D, Tsuchiya T, Onimaru Y, Tsushima H, Yoshida S, Yamada Y, Kamihira S, Tomonaga M.

Haematologica. 2008 Jan;93(1):e21-3. doi: 10.3324/haematol.12085.

39.

Donor-derived DNA in fingernails among recipients of allogeneic hematopoietic stem-cell transplants.

Imanishi D, Miyazaki Y, Yamasaki R, Sawayama Y, Taguchi J, Tsushima H, Fukushima T, Yoshida S, Sasaki H, Hata T, Tomonaga M.

Blood. 2007 Oct 1;110(7):2231-4. Epub 2007 Jun 8.

PMID:
17557896
40.

Small number of HTLV-1-positive cells frequently remains during complete remission after allogeneic hematopoietic stem cell transplantation that are heterogeneous in origin among cases with adult T-cell leukemia/lymphoma.

Yamasaki R, Miyazaki Y, Moriuchi Y, Tsutsumi C, Fukushima T, Yoshida S, Taguchi J, Inoue Y, Matsuo E, Imaizumi Y, Imanishi D, Fujimoto T, Tsushima H, Honda S, Hata T, Tsukasaki K, Tomonaga M.

Leukemia. 2007 Jun;21(6):1212-7. Epub 2007 Apr 5.

PMID:
17410191
41.

Imatinib provides durable molecular and cytogenetic responses in a practical setting for both newly diagnosed and previously treated chronic myelogenous leukemia: a study in nagasaki prefecture, Japan.

Matsuo E, Miyazaki Y, Tsutsumi C, Inoue Y, Yamasaki R, Hata T, Fukushima T, Tsushima H, Imanishi D, Imaizumi Y, Iwanaga M, Sakai M, Ando K, Sawayama Y, Ogawa D, Kawaguchi Y, Nagai K, Tsukasaki K, Ikeda S, Moriuchi Y, Yoshida S, Honda M, Taguchi J, Onimaru Y, Tsuchiya T, Tawara M, Atogami S, Yamamura M, Soda H, Yoshida Y, Matsuo Y, Nonaka H, Joh T, Takasaki Y, Kawasaki C, Momita S, Jinnai I, Kuriyama K, Tomonaga M.

Int J Hematol. 2007 Feb;85(2):132-9.

PMID:
17321991
42.

Chemokine expression in human erythroid leukemia cell line AS-E2: macrophage inflammatory protein-3alpha/CCL20 is induced by inflammatory cytokines.

Inoue Y, Tsushima H, Ando K, Sawayama Y, Sakai M, Yamasaki R, Matsuo E, Tsutsumi C, Imaizumi Y, Iwanaga M, Imanishi D, Taguchi J, Miyazaki Y, Tomonaga M.

Exp Hematol. 2006 Jan;34(1):19-26.

PMID:
16413387
43.

Primary malignant lymphoma of the female urethra.

Inuzuka S, Koga S, Imanishi D, Matsuo T, Kanetake H.

Anticancer Res. 2003 May-Jun;23(3C):2925-7. Review.

PMID:
12926136
44.

Human T cell leukemia virus type-I Tax activates human macrophage inflammatory protein-3 alpha/CCL20 gene transcription via the NF-kappa B pathway.

Imaizumi Y, Sugita S, Yamamoto K, Imanishi D, Kohno T, Tomonaga M, Matsuyama T.

Int Immunol. 2002 Feb;14(2):147-55.

PMID:
11809734
45.

Identification of a novel cytokine response element in the human IFN regulatory factor-1 gene promoter.

Imanishi D, Yamamoto K, Tsushima H, Miyazaki Y, Kuriyama K, Tomonaga M, Matsuyama T.

J Immunol. 2000 Oct 1;165(7):3907-16.

46.

Fas antigen (CD95) in pure erythroid cell line AS-E2 is induced by interferon-gamma and tumor necrosis factor-alpha and potentiates apoptotic death.

Tsushima H, Imaizumi Y, Imanishi D, Fuchigami K, Tomonaga M.

Exp Hematol. 1999 Mar;27(3):433-40.

PMID:
10089905
47.

[Scoring systems for predicting prognoses of the patients with AML treated according to the Japan Adult Leukemia Study Group (JALSG) protocols].

Kuriyama K, Yoshida S, Imanishi D, Honda S, Mine M, Asanaga M.

Rinsho Ketsueki. 1998 Feb;39(2):98-102. Review. Japanese. No abstract available.

PMID:
9545809
48.

[Philadelphia chromosome (BCR/ABL)--positive acute lymphoblastic leukemia: clinical characteristics and prognostic analysis for the effective therapeutic strategy].

Nagai K, Hayashibara T, Imanishi D, Honda S, Mine M, Kuriyama K, Asanaga M.

Rinsho Ketsueki. 1997 May;38(5):414-21. Japanese. No abstract available.

PMID:
9194386

Supplemental Content

Loading ...
Support Center